Holen Sie sich die Stockscreener-App
3.35
2.13%
0.07
Schlusskurs vom Vortag:
$3.28
Offen:
$3.24
24-Stunden-Volumen:
59,470
Relative Volume:
0.25
Marktkapitalisierung:
$147.87M
Einnahmen:
$81.06M
Nettoeinkommen (Verlust:
$-55.55M
KGV:
-2.9386
EPS:
-1.14
Netto-Cashflow:
$-47.98M
1W Leistung:
+10.56%
1M Leistung:
+32.94%
6M Leistung:
-11.84%
1J Leistung:
-39.64%
1-Tages-Spanne:
$3.18
$3.36
1-Wochen-Bereich:
$2.94
$3.65
52-Wochen-Spanne:
$2.03
$8.45
Sight Sciences Inc Stock (SGHT) Company Profile
Firmenname
Sight Sciences Inc
Sektor
Branche
Telefon
(415) 889-0550
Adresse
4040 CAMPBELL AVE,, MENLO PARK
Vergleichen Sie SGHT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
3.35 | 147.87M | 81.06M | -55.55M | -47.98M | -1.14 |
|
ABT
Abbott Laboratories
|
132.57 | 233.05B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.75 | 155.05B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
391.95 | 146.77B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.36 | 106.66B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
76.51 | 44.02B | 5.54B | 4.18B | 623.10M | 7.00 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-11-04 | Herabstufung | Lake Street | Buy → Hold |
| 2024-08-21 | Eingeleitet | Lake Street | Buy |
| 2023-09-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-09-12 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-09-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-08-24 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-01-06 | Hochstufung | Stifel | Hold → Buy |
| 2022-10-04 | Eingeleitet | Needham | Hold |
| 2022-07-26 | Eingeleitet | Stifel | Hold |
| 2022-02-03 | Eingeleitet | William Blair | Outperform |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
Alle ansehen
Sight Sciences Inc Aktie (SGHT) Neueste Nachrichten
Sight Sciences to Present at the Stifel 2025 Virtual Ophthalmology Forum on May 27th - The Manila Times
Sight Sciences Reveals New Ophthalmology Tech Updates at Exclusive Stifel 2025 ForumLive Webcast Available - Stock Titan
Sight Sciences, Inc. (NASDAQ:SGHT) Surges 44% Yet Its Low P/S Is No Reason For Excitement - simplywall.st
Sight Sciences, Inc. (NASDAQ:SGHT) Shares Acquired by Wells Fargo & Company MN - Defense World
Sight Sciences, Inc. (NASDAQ:SGHT) Shares Purchased by Barclays PLC - Defense World
Sight Sciences (NASDAQ:SGHT) Price Target Raised to $3.00 - Defense World
Sight Sciences, Inc. (NASDAQ:SGHT) Q1 2025 Earnings Call Transcript - Insider Monkey
Analysts Have Conflicting Sentiments on These Healthcare Companies: Evolent Health (EVH), Verastem (VSTM) and Sight Sciences (SGHT) - The Globe and Mail
Sight Sciences (SGHT) Price Target Raised Amid Growth Potential - GuruFocus
Sight Sciences (SGHT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
Sight Sciences, Inc. Earnings Call: Mixed Results and Strategic Focus - TipRanks
Earnings call transcript: Sight Sciences misses Q1 2025 EPS forecast, stock rises - Investing.com Nigeria
Sight Sciences stock holds as Needham reiterates rating By Investing.com - Investing.com Nigeria
Sight Sciences stock holds as Needham reiterates rating - Investing.com
Sight Sciences: Balancing Resilience and Caution Amid Tariff Challenges - TipRanks
Sight Sciences (SGHT): Analyst Raises Price Target Despite Hold Rating | SGHT Stock News - GuruFocus
Sight Sciences Inc (SGHT) Q1 2025 Earnings Call Highlights: Navigating Market Challenges and ... By GuruFocus - Investing.com Canada
Sight Sciences Reports Q1 2025 Earnings and Outlook - TipRanks
Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance - GlobeNewswire
Sight Sciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
SGHT Updates 2025 Financial Guidance Amidst Medicare Changes | SGHT Stock News - GuruFocus
Sight Sciences reports Q1 EPS (28c) , consensus (23c) - TipRanks
Sight Sciences Reports Q1 2025 Financial Results - TipRanks
Selling Sight Sciences Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - simplywall.st
Marshall Wace LLP Takes Position in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Average Recommendation of “Hold” from Analysts - Defense World
Sight Sciences, Inc. (NASDAQ:SGHT) Shares Bought by JPMorgan Chase & Co. - Defense World
Head to Head Survey: Pulse Biosciences (NASDAQ:PLSE) & Sight Sciences (NASDAQ:SGHT) - Defense World
Sight Sciences, Inc. (NASDAQ:SGHT) Shares Acquired by Renaissance Technologies LLC - Defense World
Geode Capital Management LLC Boosts Stock Position in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025 - The Manila Times
Sight Sciences, Inc. to Report First Quarter Financial Results on May 8, 2025 - Nasdaq
Eyecare Tech Leader Sight Sciences Sets Q1 2025 Earnings Date: What Investors Should Watch - Stock Titan
Sight Sciences (SGHT) to Release Earnings on Thursday - Defense World
Sight Sciences stock hits 52-week low at $2.54 amid market challenges - MSN
Sight Sciences Announces the Release of its Sustainability Report - GlobeNewswire
Sight Sciences Sustainability Report Reveals Strong Gender Pay Equity, 14% Staff Retention Boost - Stock Titan
Sight Sciences Appoints Gary Burbach to its Board of Directors - The Manila Times
Sight Sciences Appoints Gary Burbach to Board of Directors - VisionMonday.com
Sight Sciences appoints new board member By Investing.com - Investing.com India
Sight Sciences appoints new board member - Investing.com Australia
Sight Sciences Strengthens Board with Medtech Veteran as Glaucoma, Dry Eye Markets Transform - Stock Titan
Sight Sciences Launches OMNI® Edge Surgical System to Enhance Glaucoma Treatment - Nasdaq
Sight Sciences to Debut OMNI® Edge Surgical System at the - GlobeNewswire
Sight Sciences Unveils OMNI Edge: Next-Gen Glaucoma Surgery System with 2X Capacity | SGHT Stock News - Stock Titan
Sight Sciences, Inc. (NASDAQ:SGHT) Shares Acquired by American Century Companies Inc. - Defense World
Finanzdaten der Sight Sciences Inc-Aktie (SGHT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sight Sciences Inc-Aktie (SGHT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Badawi Paul | President and CEO |
Apr 01 '25 |
Sale |
2.30 |
24,174 |
55,673 |
6,010,580 |
| Link Matthew | Chief Commercial Officer |
Apr 02 '25 |
Sale |
2.31 |
5,042 |
11,642 |
830,551 |
| Badawi David | Chief Technology Officer |
Apr 01 '25 |
Sale |
2.30 |
5,980 |
13,772 |
1,836,704 |
| Bauerlein Alison | Chief Financial Officer |
Apr 02 '25 |
Sale |
2.31 |
19,397 |
44,788 |
649,794 |
0.87%
0.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):